Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

Fri, 5th Jun 2020

JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 3200p (from 3300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

FTSE 100 Latest
Value6,095.41
Change45.79